Australian-based CRO Novotech has entered into a collaboration with Bangkok’s Phramongkutklao hospital and clinical research center to conduct early phase clinical trials.
Under the agreement, Novotech will partner with the hospital and will conduct early phase studies at its research center while it provides feasibility assessments and recruit patients for studies.
Dr. Yooni Kim, Novotech’s executive director of Asian operations, cited Bangkok’s rapid growth and increasing focus on advanced medical care and supporting facilities.
The collaboration “means Novotech will have dedicated clinical experts within the hospital to support and prioritize rapid clinical processes” for its biopharma clients, Kim said in a statement.
Novotech has said increasing use of Asia and Asia-Pacific regions as sites for clinical trials supports the need for partnerships with CROs that understand and can leverage market nuances.
In July, Novotech inked a partnership with Philippines-based ophthalmology firm Asian Eye Institute for clinical research.
Financial details of that deal and the agreement with Phramongkutklao weren’t disclosed.